Metabolism and Metabolomics of Liver in Health and Disease

Metabolism and Metabolomics of Liver in Health and Disease

Women and men have probably never been concerned as much by their health as during this COVID-19 pandemic. In this context, lifestyle habits continue to be promoted as allies for daily prevention against diseases. This is valid also for metabolic diseases, among which many affect the liver and are r...

Full description

Bibliographic Details
Format:	eBook
Language:	English
Published:	Basel, Switzerland MDPI - Multidisciplinary Digital Publishing Institute 2021
Subjects:	Medicine and Nursing 1H-NMR spectroscopy acetaminophen acupuncture alcoholic liver disease arachidonic acid bile acids biomarker blood carbohydrate response element-binding protein cells cholestasis ChREBP cirrhosis de novo lipogenesis diabetes docosahexaenoic acid feces fibrosis Fibrosis GC-MS Genomics glucose homeostasis glucose production glycogen glycogen storage disease type I glycolysis heat stress HepaRG hepatotoxicity hexosamine imflammation in vitro inflammation lipid homeostasis lipid metabolism lipidomics liquid chromatography liquid chromatography-mass spectrometry liver Liver biopsy liver function mass spectrometry metabolic pathway metabolic profile metabolic stress metabolomics Metabolomics metabolomics quantitative profiling multivariate statistical analysis NAFL NAFLD NASH nicotinamide non-alcoholic fatty liver disease non-alcoholic steatohepatitis nonalcoholic fatty liver nonalcoholic fatty liver disease nonalcoholic steatohepatitis nuclear magnetic resonance spectroscopy oxidative stress pentose phosphate pathway premalignant primary mouse hepatocytes Proteomics rat plasma reference toxicants sodium saccharin standard operating procedures steatosis tandem mass spectrometry tissue transcription factors Transcriptomics urine
Online Access:	Open Access: DOAB: description of the publication Open Access: DOAB, download the publication

Similar Items

Distinguishing NASH Histological Severity Using a Multiplatform Metabolomics Approach
by: George N. Ioannou, et al.
Published: (2020-04-01)

Metabolomic Study of High-Fat Diet-Induced Obese (DIO) and DIO Plus CCl<sub>4</sub>-Induced NASH Mice and the Effect of Obeticholic Acid
by: Nanlin Zhu, et al.
Published: (2021-06-01)

Circular RNA as An Epigenetic Regulator in Chronic Liver Diseases
by: Xianhui Zeng, et al.
Published: (2021-07-01)

The OMICs Window into Nonalcoholic Fatty Liver Disease (NAFLD)
by: Lucia Carulli, et al.
Published: (2019-02-01)

Overexpression of the Vitronectin V10 Subunit in Patients with Nonalcoholic Steatohepatitis: Implications for Noninvasive Diagnosis of NASH
by: Maria Del Ben, et al.
Published: (2018-02-01)

Comparison of liver enzymes level and sonographic findings value with liver biopsy findings in nonalcoholic fatty liver disease patients
by: Mahsa Khodadoostan, et al.
Published: (2016-01-01)

A Lipidomic Analysis of Docosahexaenoic Acid (22:6, ω3) Mediated Attenuation of Western Diet Induced Nonalcoholic Steatohepatitis in Male <i>Ldlr <sup>-/-</sup></i> Mice
by: Manuel García-Jaramillo, et al.
Published: (2019-10-01)

Fatty liver diseases, bile acids, and FXR
by: Yan Zhu, et al.
Published: (2016-09-01)

A randomized double-blind study of the short-time treatment of obese patients with nonalcoholic fatty liver disease with ursodeoxycholic acid
by: V.N. Santos, et al.
Published: (2003-06-01)

Disease Progression in a Patient with Nonalcoholic Steatohepatitis
by: Ping-Huei Tseng, et al.
Published: (2008-10-01)

Non-alcoholic fatty liver disease: A review with clinical and pathological correlation
by: Yen-Ying Chen, et al.
Published: (2021-01-01)

Changed Amino Acids in NAFLD and Liver Fibrosis: A Large Cross-Sectional Study without Influence of Insulin Resistance
by: Takuma Hasegawa, et al.
Published: (2020-05-01)

Metabolomic Salivary Signature of Pediatric Obesity Related Liver Disease and Metabolic Syndrome
by: Jacopo Troisi, et al.
Published: (2019-01-01)

Obeticholic Acid: A New Era in the Treatment of Nonalcoholic Fatty Liver Disease
by: Ludovico Abenavoli, et al.
Published: (2018-10-01)

Treatment Options in Non-alcoholic Fatty Liver Disease
by: Won Kim
Published: (2017-06-01)

Circulating Levels of Pro-Neurotensin and Its Relationship with Nonalcoholic Steatohepatitis and Hepatic Lipid Metabolism
by: Beatriz Villar, et al.
Published: (2021-06-01)

The role of zinc in the prevention and treatment of nonalcoholic fatty liver disease
by: Mary Barbara, et al.
Published: (2021-09-01)

Non-alcoholic fatty liver disease – a rapidly growing indication for liver transplantation in the modern world
by: I. M. Iljinsky, et al.
Published: (2019-10-01)

Biomarkers of NAFLD progression: a lipidomics approach to an epidemic1[S]
by: D.Lee Gorden, et al.
Published: (2015-03-01)

Nonalcoholic steatohepatitis and hepatocellular carcinoma: Brazilian survey
by: Helma P. Cotrim, et al.
Published: (2016-05-01)

Gut Microbiota Dysbiosis in Patients with Biopsy-Proven Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study in Taiwan
by: Ming-Chao Tsai, et al.
Published: (2020-03-01)

Role of Neutrophils in the Pathogenesis of Nonalcoholic Steatohepatitis
by: Seonghwan Hwang, et al.
Published: (2021-10-01)

Epidemiology and natural history of NAFLD
by: Della Corte Claudia, et al.
Published: (2015-01-01)

Novel insights into the relationship between nonalcoholic fatty liver disease and osteoporosis
by: Filip R, et al.
Published: (2018-10-01)

Hepatic Stress Response Mechanisms in Progressive Human Nonalcoholic Fatty Liver Disease
by: Lake, April D.
Published: (2013)

Personal or family history of metabolic traits predispose to higher hepatotoxic effects of alcohol
by: Ajeet Singh Bhadoria, et al.
Published: (2019-01-01)

Nonalcoholic Fatty Liver Disease: Pros and Cons of Histologic Systems of Evaluation
by: Elizabeth M. Brunt
Published: (2016-01-01)

World Gastroenterology Organisation global guidelines：nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
by: ZHU Peng
Published: (2014-09-01)

Practical Diagnosis and Staging of Nonalcoholic Fatty Liver Disease: A Narrative Review
by: Jennifer Gallacher, et al.
Published: (2018-06-01)

Features of Glucose Homeostasis and Blood Lipid Spectrum in Patients with Nonalcoholic Fatty Liver Dis ease Depending on the Obesity Degree
by: Korniichuk I., et al.
Published: (2019-04-01)

Relationship of sarcopenia with steatohepatitis and advanced liver fibrosis in non-alcoholic fatty liver disease: a meta-analysis
by: Rui Yu, et al.
Published: (2018-04-01)

The Role of Lipid and Lipoprotein Metabolism in Non‐Alcoholic Fatty Liver Disease
by: Francesco Massimo Perla, et al.
Published: (2017-06-01)

Vaspin mRNA levels in the liver of morbidly obese women with nonalcoholic fatty liver disease
by: Marek Waluga, et al.
Published: (2017-09-01)

The Epidemiology, Risk Profiling and Diagnostic Challenges of Nonalcoholic Fatty Liver Disease
by: Umair Iqbal, et al.
Published: (2019-03-01)

Differentially methylated loci in NAFLD cirrhosis are associated with key signaling pathways
by: Glenn S. Gerhard, et al.
Published: (2018-07-01)

Nonalcoholic steatohepatitis and biliary sludge in people with metabolic syndrome
by: V G Radchenko, et al.
Published: (2016-09-01)

An open-label randomized control study to compare the efficacy of vitamin e versus ursodeoxycholic acid in nondiabetic and noncirrhotic Indian NAFLD patients
by: Pathik Parikh, et al.
Published: (2016-01-01)

Advances in traditional Chinese medicine for liver disease therapy in 2020
by: Lu Yang, et al.
Published: (2021-05-01)

FGF21: An Emerging Therapeutic Target for Non-Alcoholic Steatohepatitis and Related Metabolic Diseases
by: Erik J. Tillman, et al.
Published: (2020-12-01)

Multinodular fatty liver after herpes-zoster vaccine: Case report and review of the literature
by: Michael Shim, et al.
Published: (2008-10-01)